The influence of tumour type and of sphere size on microsphere nonentrapment: a study in the ratNAREDI, P; HAFSTRÖM, L.Regional cancer treatment. 1992, Vol 4, Num 5-6, pp 244-245, issn 0935-0411Article

ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arseniteHEMMINGSSON, O; ZHANG, Y; STILL, M et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 3, pp 491-499, issn 0344-5704, 9 p.Article

Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II studyDONSKOV, F; VON DER MAASE, H; HENRIKSSON, R et al.Annals of oncology. 2002, Vol 13, Num 3, pp 441-449, issn 0923-7534Article

Pharmacokinetics of cisplatin in an isolated liver perfusion system in humansNAREDI, P; HOLMBERG, S. B; HAFSTRÖM, L et al.Regional cancer treatment. 1992, Vol 4, Num 5-6, pp 254-257, issn 0935-0411Article

Aggregation of microspheres in blood flow measurementsNAREDI, P; MATTSSON, J; HAFSTROÊM, L et al.International journal of microcirculation. Clinical and experimental. 1991, Vol 10, Num 2, pp 169-180, issn 0167-6865, 12 p.Article

Influence of hepatic artery occlusion and desferrioxamine on liver-tumour growthLINDNER, P; NAREDI, P; PETERSON, A et al.International journal of cancer. 1995, Vol 63, Num 4, pp 592-596, issn 0020-7136Article

Influence of vasoactive drugs on microsphere nonentrapment in experimental rat tumoursNAREDI, P; MATTSSON, J; HAFSTROÊM, L et al.Regional cancer treatment. 1991, Vol 3, Num 5, pp 256-260, issn 0935-0411, 5 p.Article

Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalanLINDNER, P; FJÄLLING, M; HAFSTRÖM, L et al.European journal of surgical oncology. 1999, Vol 25, Num 2, pp 179-185, issn 0748-7983Article

Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administrationLINDNER, P; HEATH, D; HOWELL, S et al.Clinical cancer research. 1996, Vol 2, Num 2, pp 311-317, issn 1078-0432Article

Whole body energy expenditure protein breakdown and polyamine excretion during high dose treatment with interleukin-2 and interferon-αNAREDI, P; HAFSTRÖM, L; ZACHRISSON, H et al.The European journal of surgery. 1994, Vol 160, Num 2, pp 67-75, issn 1102-4151Article

Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell lineNAREDI, P; HEATH, D. D; ENNS, R. E et al.Cancer research (Baltimore). 1994, Vol 54, Num 24, pp 6464-6468, issn 0008-5472Article

Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol : a randomized clinical trialHAFSTRÖM, L; ENGARÅS, B; TIDEBRANT, G et al.Cancer. 1994, Vol 74, Num 10, pp 2749-2756, issn 0008-543XArticle

Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the ¹³³Xe-clearance techniqueÖMAN, M; TÖLLI, J; NAREDI, P et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 3, pp 213-218, issn 0344-5704, 6 p.Article

Histamine and cytokine therapyHELLSTRAND, K; HERMODSSON, S; NAREDI, P et al.Acta oncologica (Stockholm). 1998, Vol 37, Num 4, pp 347-353, issn 0284-186XConference Paper

Histamine in cancer immunotherapyHELLSTRAND, K; HERMODSSON, S; BRUNE, M et al.Scandinavian journal of clinical & laboratory investigation. 1997, Vol 57, Num 3, pp 193-202, issn 0036-5513Article

Isolated regional liver perfusion with tumour necrosis factor-alpha followed by hyperthermic melphalan perfusionHAFSTRÖM, L; HOLMBERG, S. B; LINDNER, P et al.Regional cancer treatment. 1994, Vol 7, Num 3-4, pp 172-176, issn 0935-0411Article

Cytotoxicity of liver macrophages against liver tumours : influence of betamethasone, indomethacin and allopurinolHOLMBERG, S. B; LINDNER, P; NAREDI, P et al.Anticancer research. 1991, Vol 11, Num 5, pp 1827-1830, issn 0250-7005Article

Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in SwedenERIKSSON, H; LYTH, J; HANSSON, J et al.European journal of cancer (1990). 2013, Vol 49, Num 12, pp 2705-2716, issn 0959-8049, 12 p.Article

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancerÖHLUND, D; LUNDIN, C; ARDNOR, B et al.British journal of cancer. 2009, Vol 101, Num 1, pp 91-97, issn 0007-0920, 7 p.Article

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survivalDONSKOV, F; BENNEDSGAARD, K. M; VON DER MAASE, H et al.British journal of cancer. 2002, Vol 87, Num 2, pp 194-201, issn 0007-0920Article

Hepatic artery occlusion and energy charge in rat liver tumourLINDNER, P; BIBER, B; GUSTAVSSON, B et al.Annals of oncology. 1994, Vol 5, Num 10, pp 961-963, issn 0923-7534Article

Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-a2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanomaMIDDLETON, M; HAUSCHILD, A; THOMSON, D et al.Annals of oncology. 2007, Vol 18, Num 10, pp 1691-1697, issn 0923-7534, 7 p.Article

¹³³Xe clearance estimates the effect of vasopressin on peritoneal blood flow in ratsÖMAN, M; TÖLLI, J; BLIND, P. J et al.Hepato-gastroenterology. 2004, Vol 51, Num 58, pp 1037-1041, issn 0172-6390, 5 p.Article

Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IVÖMAN, M; BLIND, P. J; NAREDI, P et al.European journal of surgical oncology. 2001, Vol 27, Num 5, pp 477-481, issn 0748-7983Article

Quantitative measurements of collateral arterial blood flow in nonarterialized rat liver graftsSVENSSON, G; NAREDI, P; HAFSTRÖM, L. O et al.Transplant international. 1994, Vol 7, Num 2, pp 136-139, issn 0934-0874Article